Eventide Healthcare & Life Sciences Fund CLDX Holdings History
Eventide Healthcare & Life Sciences Fund's Celldex Therapeutics Inc Holding Summary
As of 2024-12-31, MUTUAL FUND SERIES TRUST held 1.36 Mil shares of Celldex Therapeutics Inc(CLDX), totaling $34.27 Mil. This investment constitutes 2.92% of their stock portfolio, and MUTUAL FUND SERIES TRUST now holds 2.04% of the outstanding Celldex Therapeutics Inc(CLDX) stock.
The initial trade took place in 2020Q2. And since then Eventide Healthcare & Life Sciences Fund has made 9 purchases of CLDX, at an average price of $32.72, for a total of 13.05 Mil shares. In addition, there have been 5 sales at an average price of $37.58 for 11.70 Mil shares. Based on historical transaction data and CLDX's current price of $20.34, Eventide Healthcare & Life Sciences Fund's estimated gain on his CLDX holdings is $40.10 Mil, reflecting a 9.39% gain to date.
Eventide Healthcare & Life Sciences Fund CLDX ($20.34) Holding Chart
Eventide Healthcare & Life Sciences Fund CLDX ($20.34) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1